Skip to main content
. 2022 Sep 26;18:2199–2210. doi: 10.2147/NDT.S376717

Table 3.

Demographic, Clinical, Radiological and Biochemical Factors for 90-Day Poor Outcome After Acute Intracerebral Hemorrhage

Components Poor Outcome Good Outcome P value
Number 46 (43.8%) 59 (56.2%)
Age (years) 65.8±15.7 61.9±13.8 0.232
Sex (male/female) 28/18 41/18 0.356
Hypertension 31 (67.3%) 42 (71.2%) 0.675
Diabetes mellitus 10 (21.7%) 9 (15.3%) 0.392
Hyperlipidemia 13 (28.3%) 12 (20.3%) 0.344
Current smoking 8 (17.4%) 19 (32.2%) 0.085
Alcohol consumption 15 (32.6%) 13 (22.0%) 0.224
Use of statins drugs 7 (15.2%) 12 (20.3%) 0.499
Use of antiplatelet drugs 5 (10.9%) 7 (11.9%) 0.874
Use of anticoagulation drugs 2 (4.3%) 1 (1.7%) 0.826
Admission time (h) 5.0 (3.0–7.3) 6.0 (3.0–7.0) 0.420
Blood-collection time (h) 5.5 (3.9–8.5) 7.0 (4.5–8.0) 0.293
Systolic arterial pressure (mmHg) 155.7±25.4 150.3±25.4 0.376
Diastolic arterial pressure (mmHg) 91.2±17.2 87.4±15.9 0.222
Lobar hemorrhage 9 (19.6%) 12 (20.3%) 0.922
Infratentorial hemorrhage 8 (17.4%) 11 (18.6%) 0.869
Intraventricular hemorrhage 10 (21.7%) 9 (15.3%) 0.392
Subarachnoid hemorrhage 2 (4.3%) 1 (1.7%) 0.826
Glasgow Coma Scale score 10 (9–11) 13 (12–14) <0.001
Hematoma volume (mL) 29.8 (15.5–42.9) 10.5 (6.0–19.5) <0.001
Blood leucocyte count (×109/l) 7.5 (5.6–10.2) 7.0 (5.5–8.9) 0.342
Plasma glucose levels (mmol/l) 7.1 (6.1–8.8) 5.7 (5.0–7.9) 0.020
Plasma potassium levels (mmol/l) 3.75±0.44 3.75±0.36 0.682
Plasma CRP levels (mg/l) 4.0 (1.6–14.9) 2.6 (2.0–5.0) 0.175
Plasma SIRT3 levels (ng/mL) 6.1 (3.6–10.2) 12.2 (9.6–13.3) <0.001

Notes: Quantitative data were reported as medians with 25th–75th percentiles or the mean ± standard deviation as appropriate. Qualitative data were presented as counts (proportions). Intergroup comparisons of various variables were performed using the χ2 test or Fisher’s exact test for qualitative data, and Mann–Whitney U-test for quantitative data. Glasgow Outcome Scale score of 1–3 was designated as poor outcome. CRP indicates C-reactive protein.